Retrograde cardioplegia: when and how. A review

J Vaage1

  • 1Department of Thoracic Surgery, Karolinska Hospital, Stockholm, Sweden.

Scandinavian Journal of Thoracic and Cardiovascular Surgery. Supplementum
|January 1, 1993
PubMed

Insights

Retrograde cardioplegia, delivered via balloon catheters and coronary sinus cannulation, offers technical advantages in cardiac surgery. This method may benefit patients with severe coronary artery disease, enhancing surgical options.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Anesthesia
  • Myocardial Protection

Background:

  • Retrograde cardioplegia is increasingly utilized due to advancements in delivery techniques.
  • Balloon catheters now enable blind transatrial cannulation of the coronary sinus for retrograde delivery.
  • This approach presents specific technical benefits in certain surgical scenarios.

Purpose of the Study:

  • To highlight the growing popularity and technical advantages of retrograde cardioplegia.
  • To explore potential benefits for specific patient subgroups, particularly those with severe coronary stenoses or occlusions.
  • To position retrograde cardioplegia as a valuable addition to cardiac surgical techniques.

Main Methods:

  • Utilizes balloon catheters for transatrial cannulation of the coronary sinus.
  • Facilitates retrograde delivery of cardioplegic solutions.
  • Describes technical advantages and potential patient benefits.

Main Results:

  • Retrograde cardioplegia offers distinct technical advantages in various surgical situations.
  • Potential benefits for patients with severe coronary stenoses/occlusion are suggested, though not yet clinically documented.
  • The technique is considered a valuable addition to the cardiac surgeon's toolkit.

Conclusions:

  • Retrograde cardioplegia is a valuable technique in cardiac surgery.
  • Its utility is enhanced by advancements in cannulation methods.
  • Further clinical documentation may solidify its role, especially in complex coronary artery disease cases.

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...